$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 2.52 | 2,500 | 6,300 | 22,292 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 3.53 | 2,500 | 8,825 | 18,647 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Sell | S | 11.52 | 10,000 | 115,160 | 50,000 | 60 K to 50 K (-16.67 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Buy | M | 11.52 | 10,000 | 115,160 | 60,000 | 50 K to 60 K (+20.00 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | M | 6.06 | 10,110 | 61,267 | 24,890 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Sell | S | 11.51 | 10,110 | 116,359 | 50,000 | 60.1 K to 50 K (-16.82 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Buy | M | 11.51 | 10,110 | 116,359 | 60,110 | 50 K to 60.1 K (+20.22 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | M | 2.45 | 2,812 | 6,889 | 42,188 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | M | 2.52 | 3,462 | 8,724 | 31,538 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | M | 3.53 | 4,374 | 15,440 | 30,626 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Sell | S | 11.51 | 10,648 | 122,568 | 50,000 | 60.6 K to 50 K (-17.56 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Buy | M | 11.51 | 10,648 | 122,568 | 60,648 | 50 K to 60.6 K (+21.30 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 2.45 | 2,812 | 6,889 | 42,188 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 2.52 | 3,463 | 8,727 | 31,537 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 3.53 | 2,624 | 9,263 | 25,376 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 4.38 | 1,896 | 8,304 | 33,104 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 4.16 | 3,250 | 13,520 | 9,750 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Sell | S | 11.51 | 14,045 | 161,669 | 50,000 | 64 K to 50 K (-21.93 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Buy | M | 11.51 | 14,045 | 161,669 | 64,045 | 50 K to 64 K (+28.09 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.33 | 268,322 | 1,428,815 | 0 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 11.49 | 268,322 | 3,082,242 | 83,499 | 351.8 K to 83.5 K (-76.27 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 11.49 | 268,322 | 3,082,242 | 351,821 | 83.5 K to 351.8 K (+321.35 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.81 | 416 | 1,169 | 19,584 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 4.16 | 12,583 | 52,345 | 25,167 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 11.51 | 12,999 | 149,595 | 200,000 | 213 K to 200 K (-6.10 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 11.51 | 416 | 4,787 | 212,999 | 212.6 K to 213 K (+0.20 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 11.51 | 12,583 | 144,808 | 212,583 | 200 K to 212.6 K (+6.29 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.45 | 7,500 | 18,375 | 82,500 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.52 | 2,655 | 6,691 | 51,534 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 3.53 | 5,080 | 17,932 | 48,420 | |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 11.51 | 15,235 | 175,294 | 100,000 | 115.2 K to 100 K (-13.22 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 11.51 | 7,500 | 86,295 | 115,235 | 107.7 K to 115.2 K (+6.96 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 11.51 | 2,655 | 30,548 | 107,735 | 105.1 K to 107.7 K (+2.53 %) |
| Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 11.51 | 5,080 | 58,450 | 105,080 | 100 K to 105.1 K (+5.08 %) |
| Feb 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 8.43 | 41,441 | 349,493 | 828,840 | 870.3 K to 828.8 K (-4.76 %) |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | A | 8.61 | 45,000 | 387,450 | 45,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | A | 8.61 | 45,000 | 387,450 | 45,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | A | 8.61 | 45,000 | 387,450 | 45,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | A | 8.61 | 45,000 | 387,450 | 45,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 8.61 | 45,000 | 387,450 | 45,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | A | 8.61 | 45,000 | 387,450 | 45,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Business Planni ... | Option Exercise | A | 8.61 | 45,000 | 387,450 | 45,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Option Exercise | A | 8.61 | 50,000 | 430,500 | 50,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | A | 8.61 | 45,000 | 387,450 | 45,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 11.19 | 230,000 | 2,573,700 | 230,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | A | 8.61 | 45,000 | 387,450 | 45,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 8.61 | 90,000 | 774,900 | 90,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 8.61 | 80,000 | 688,800 | 80,000 | |
| Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 8.61 | 90,000 | 774,900 | 90,000 | |
| Jan 26 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 8.10 | 41,441 | 335,548 | 870,281 | 911.7 K to 870.3 K (-4.55 %) |
| Jan 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | M | 5.33 | 4,667 | 24,852 | 0 | |
| Jan 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Sell | S | 9.00 | 4,667 | 42,003 | 50,000 | 54.7 K to 50 K (-8.54 %) |
| Jan 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Buy | M | 9.00 | 4,667 | 42,003 | 54,667 | 50 K to 54.7 K (+9.33 %) |
| Dec 24 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 8.43 | 41,441 | 349,348 | 911,722 | 953.2 K to 911.7 K (-4.35 %) |
| Dec 22 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 7.88 | 41,441 | 326,555 | 953,163 | 994.6 K to 953.2 K (-4.17 %) |
| Dec 15 2014 | FOLD | AMICUS THERAPEUTIC ... | LOVE TED W | Director | Grant | A | 7.83 | 32,000 | 250,637 | 142,000 | 110 K to 142 K (+29.09 %) |
| Dec 08 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.33 | 89,000 | 473,925 | 0 | |
| Dec 08 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 8.36 | 89,000 | 743,907 | 109,083 | 198.1 K to 109.1 K (-44.93 %) |
| Dec 08 2014 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | P | 8.36 | 89,000 | 743,907 | 198,083 | 109.1 K to 198.1 K (+81.59 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 4.16 | 5,000 | 20,800 | 25,000 | |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 3.53 | 10,000 | 35,300 | 20,000 | |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 2.81 | 10,000 | 28,100 | 550 | |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Sell | S | 8.00 | 25,000 | 200,000 | 50,000 | 75 K to 50 K (-33.33 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | P | 8.00 | 5,000 | 40,000 | 75,000 | 70 K to 75 K (+7.14 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | P | 8.00 | 10,000 | 80,000 | 70,000 | 60 K to 70 K (+16.67 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | P | 8.00 | 10,000 | 80,000 | 60,000 | 50 K to 60 K (+20.00 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | M | 4.16 | 3,500 | 14,560 | 8,149 | |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Sell | S | 8.00 | 3,500 | 28,000 | 50,000 | 53.5 K to 50 K (-6.54 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Buy | P | 8.00 | 3,500 | 28,000 | 53,500 | 50 K to 53.5 K (+7.00 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 4.16 | 4,500 | 18,720 | 20,500 | |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Sell | S | 8.00 | 4,500 | 36,000 | 50,000 | 54.5 K to 50 K (-8.26 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Buy | P | 8.00 | 4,500 | 36,000 | 54,500 | 50 K to 54.5 K (+9.00 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 4.16 | 7,000 | 29,120 | 13,000 | |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Sell | S | 8.00 | 7,000 | 56,000 | 50,000 | 57 K to 50 K (-12.28 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Buy | P | 8.00 | 7,000 | 56,000 | 57,000 | 50 K to 57 K (+14.00 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | M | 3.53 | 8,103 | 28,604 | 26,897 | |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Sell | S | 8.00 | 8,103 | 64,824 | 50,000 | 58.1 K to 50 K (-13.95 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Buy | P | 8.00 | 8,103 | 64,824 | 58,103 | 50 K to 58.1 K (+16.21 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 4.16 | 7,250 | 30,160 | 37,750 | |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 8.00 | 7,250 | 58,000 | 200,000 | 207.3 K to 200 K (-3.50 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | P | 8.00 | 7,250 | 58,000 | 207,250 | 200 K to 207.3 K (+3.63 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 3.53 | 10,000 | 35,300 | 53,500 | |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 8.00 | 10,000 | 80,000 | 100,000 | 110 K to 100 K (-9.09 %) |
| Nov 25 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | P | 8.00 | 10,000 | 80,000 | 110,000 | 100 K to 110 K (+10.00 %) |
| Nov 19 2014 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.50 | 2,100,000 | 13,650,000 | 14,439,444 | 12.3 M to 14.4 M (+17.02 %) |
| Oct 28 2014 | FOLD | AMICUS THERAPEUTIC ... | GLAXOSMITHKLINE PLC | Sell | S | 5.29 | 11,315,825 | 59,872,030 | 0 | 11.3 M to 0 (-100.00 %) | |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | M | 3.53 | 3,200 | 11,296 | 9,800 | |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Sell | S | 7.00 | 3,200 | 22,400 | 50,000 | 53.2 K to 50 K (-6.02 %) |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Buy | P | 7.00 | 3,200 | 22,400 | 53,200 | 50 K to 53.2 K (+6.40 %) |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | M | 4.16 | 3,351 | 13,940 | 11,649 | |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | M | 3.53 | 3,461 | 12,217 | 5,289 | |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Sell | S | 7.00 | 6,812 | 47,684 | 50,000 | 56.8 K to 50 K (-11.99 %) |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Buy | P | 7.00 | 6,812 | 47,684 | 56,812 | 50 K to 56.8 K (+13.62 %) |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 3.53 | 13,853 | 48,901 | 21,147 | |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Sell | S | 7.00 | 13,853 | 96,971 | 50,000 | 63.9 K to 50 K (-21.70 %) |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Buy | P | 7.00 | 13,853 | 96,971 | 63,853 | 50 K to 63.9 K (+27.71 %) |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | M | 3.32 | 3,964 | 13,160 | 6,036 | |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | M | 2.81 | 4,588 | 12,892 | 1,840 | |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Sell | S | 7.00 | 8,552 | 59,864 | 50,000 | 58.6 K to 50 K (-14.61 %) |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Buy | P | 7.00 | 8,552 | 59,864 | 58,552 | 50 K to 58.6 K (+17.10 %) |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 3.53 | 10,000 | 35,300 | 63,500 | |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 7.00 | 10,000 | 70,000 | 100,000 | 110 K to 100 K (-9.09 %) |
| Oct 06 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | P | 7.00 | 10,000 | 70,000 | 110,000 | 100 K to 110 K (+10.00 %) |
| Oct 02 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | M | 2.52 | 10,208 | 25,724 | 24,792 | |
| Oct 02 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Sell | S | 6.01 | 10,208 | 61,303 | 50,000 | 60.2 K to 50 K (-16.95 %) |
| Oct 02 2014 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Buy | P | 6.01 | 10,208 | 61,303 | 60,208 | 50 K to 60.2 K (+20.42 %) |
| Oct 02 2014 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | M | 3.53 | 750 | 2,648 | 13,000 | |
| Oct 02 2014 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | M | 2.52 | 4,009 | 10,103 | 9,741 | |
| Oct 02 2014 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Sell | S | 5.99 | 4,759 | 28,514 | 50,000 | 54.8 K to 50 K (-8.69 %) |
| Oct 02 2014 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Buy | P | 5.99 | 4,759 | 28,514 | 54,759 | 50 K to 54.8 K (+9.52 %) |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 2.81 | 8,000 | 22,480 | 0 | |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 3.32 | 10,000 | 33,200 | 0 | |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 2.52 | 10,208 | 25,724 | 24,792 | |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Sell | S | 6.09 | 28,208 | 171,804 | 50,000 | 78.2 K to 50 K (-36.07 %) |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Buy | P | 6.09 | 28,208 | 171,804 | 78,208 | 50 K to 78.2 K (+56.42 %) |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 3.53 | 3,000 | 10,590 | 73,500 | |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.52 | 22,311 | 56,224 | 54,189 | |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 6.09 | 25,311 | 154,111 | 100,000 | 125.3 K to 100 K (-20.20 %) |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | P | 6.09 | 25,311 | 154,111 | 125,311 | 100 K to 125.3 K (+25.31 %) |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | M | 2.81 | 6,000 | 16,860 | 0 | |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | M | 2.52 | 4,738 | 11,940 | 11,512 | |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Sell | S | 6.10 | 10,738 | 65,465 | 50,000 | 60.7 K to 50 K (-17.68 %) |
| Oct 01 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Buy | P | 6.10 | 10,738 | 65,465 | 60,738 | 50 K to 60.7 K (+21.48 %) |
| Aug 29 2014 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | M | 2.81 | 10,000 | 28,100 | 0 | |
| Aug 29 2014 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Sell | S | 6.50 | 10,000 | 65,000 | 11,933 | 21.9 K to 11.9 K (-45.59 %) |
| Aug 29 2014 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Buy | P | 6.50 | 10,000 | 65,000 | 21,933 | 11.9 K to 21.9 K (+83.80 %) |
| Aug 29 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | M | 3.32 | 5,000 | 16,600 | 0 | |
| Aug 29 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Sell | S | 7.00 | 5,000 | 35,000 | 50,000 | 55 K to 50 K (-9.09 %) |
| Aug 29 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Buy | P | 7.00 | 5,000 | 35,000 | 55,000 | 50 K to 55 K (+10.00 %) |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | M | 3.32 | 5,000 | 16,600 | 5,000 | |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Sell | S | 6.00 | 5,000 | 30,000 | 50,000 | 55 K to 50 K (-9.09 %) |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Buy | P | 6.00 | 5,000 | 30,000 | 55,000 | 50 K to 55 K (+10.00 %) |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 3.53 | 5,000 | 17,650 | 30,000 | |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 2.81 | 7,450 | 20,935 | 10,550 | |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Sell | S | 6.00 | 12,450 | 74,700 | 51,708 | 64.2 K to 51.7 K (-19.41 %) |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | P | 6.00 | 5,000 | 30,000 | 64,158 | 59.2 K to 64.2 K (+8.45 %) |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | P | 6.00 | 7,450 | 44,700 | 59,158 | 51.7 K to 59.2 K (+14.41 %) |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 3.53 | 7,000 | 24,710 | 28,000 | |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Sell | S | 6.00 | 7,000 | 42,000 | 50,000 | 57 K to 50 K (-12.28 %) |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Buy | P | 6.00 | 7,000 | 42,000 | 57,000 | 50 K to 57 K (+14.00 %) |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 3.53 | 7,000 | 24,710 | 78,000 | |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 6.00 | 7,000 | 42,000 | 200,000 | 207 K to 200 K (-3.38 %) |
| Aug 26 2014 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | P | 6.00 | 7,000 | 42,000 | 207,000 | 200 K to 207 K (+3.50 %) |
| Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 2.81 | 7,000 | 19,670 | 18,000 | |
| Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Sell | S | 5.40 | 7,000 | 37,800 | 51,708 | 58.7 K to 51.7 K (-11.92 %) |
| Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | P | 5.40 | 7,000 | 37,800 | 58,708 | 51.7 K to 58.7 K (+13.54 %) |
| Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | M | 2.81 | 6,080 | 17,085 | 420 | |
| Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Sell | S | 5.40 | 6,080 | 32,832 | 50,000 | 56.1 K to 50 K (-10.84 %) |
| Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Buy | P | 5.40 | 6,080 | 32,832 | 56,080 | 50 K to 56.1 K (+12.16 %) |
| Aug 21 2014 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 2.81 | 7,810 | 21,946 | 190 |